Loading...
The Financial Express

Oxford University to test vaccine response among children

| Updated: February 14, 2021 08:50:21


A vial of the Oxford University/AstraZeneca COVID-19 vaccine is seen at the Lochee Health Centre in Dundee, Scotland, Britain Jan 4, 2021. REUTERS A vial of the Oxford University/AstraZeneca COVID-19 vaccine is seen at the Lochee Health Centre in Dundee, Scotland, Britain Jan 4, 2021. REUTERS

The University of Oxford has launched a study to assess the safety and immune response of the COVID-19 vaccine it has developed with AstraZeneca Plc in children for the first time, it said on Saturday.

The new mid-stage trial will determine whether the vaccine is effective on people between the ages of 6 and 17, according to an emailed statement from the university.

Around 300 volunteers will be enrolled and first inoculations are expected this month, Oxford said.

The two-dose Oxford/AstraZeneca vaccine has been hailed as a 'vaccine for the world' because it is cheaper and easier to distribute than some rivals.

AstraZeneca has a target to produce 3.0 billion doses this year and aims to produce over 200 million doses per month by April.

 

Share if you like

Filter By Topic